RT Journal Article
T1 Sars-Cov-2 Infection in Patients on Long-Term Treatment with Macrolides in Spain: A National Cross-Sectional Study.
A1 Meseguer Barros, Carmen Marina
A1 Alzueta Isturiz, Natalia
A1 Sainz de Rozas Aparicio, Rita
A1 Vizcaíno, Rafael Aguilella
A1 López Esteban, Laura
A1 Anaya Ordóñez, Sonia
A1 Lekue Alkorta, Itxasne
A1 Martín Suances, Salvadora
A1 Jiménez Arce, Jorge Ignacio
A1 Fernández Vicente, Maite
A1 Borrego Izquierdo, Yolanda
A1 Prieto Sánchez, Raquel
A1 Casado Casuso, Silvia
A1 Madridejos, Rosa
A1 Verde, Carmen Marquina
A1 Tomás Sanz, Rosa
A1 Oro Fernández, María
A1 Gallardo Borge, Sara
A1 Lázaro López, Eva
A1 Pina Gadea, María Belén
A1 Pereira Pía, Mercedes
A1 Maestre-Sánchez, María Victoria
A1 Ribes-Murillo, Esther
A1 Gómez de Oña, Constanza
A1 María Jesús Lallana, Álvarez
A1 Celaya Lecea, Concepción
A1 Prado Prieto, María Ana
A1 Aranguez Ruiz, Aranzazu
A1 Olmo Quintana, Vicente
A1 Villén Romero, Noemí
A1 Payá Giner, Carolina
A1 Lloret Callejo, Angeles
A1 Fernández Ferreiro, Alvaro
A1 Basagoiti Carreño, Blanca
A1 Iglesias Iglesias, Ana Aurelia
A1 Martín Alonso, Antonio
A1 Díez Alcántara, Ana
A1 Marco Tejón, Esther
A1 Lestón Vázquez, Marta
A1 Ariza Copado, Mª Ángeles
A1 Aparicio Cueva, Marta
A1 Escudero Vilaplana, Belén
A1 Nicieza, Marisa
A1 Picazo Sanchiz, Gracia
A1 Silva Riádigos, Genma María
A1 Sánchez, Lucía Jamart
A1 García Álvarez, Ángel
A1 García Bonilla, Antonio
A1 Herrero Delicado, Rafael
A1 Arroyo Pineda, Virginia
A1 de la Hija, Belén
A1 Troncoso Mariño, Amelia
A1 Tofiño González, Isabel
A1 Mateu García, Mónica Susana
A1 García Vázquez, Pablo
A1 Pérez Martín, Joaquín
A1 Fernández-Urrusuno, Rocío
K1 COVID-19
K1 SARS-CoV-2
K1 ambulatory care
K1 azithromycin
K1 long-term treatment
K1 macrolides
K1 outpatients
AB The aim of this study was to know the prevalence and severity of COVID-19 in patients treated with long-term macrolides and to describe the factors associated with worse outcomes. A cross-sectional study was conducted in Primary Care setting. Patients with macrolides dispensed continuously from 1 October 2019 to 31 March 2020, were considered. Main outcome: diagnosis of coronavirus disease-19 (COVID-19). Secondary outcomes: symptoms, severity, characteristics of patients, comorbidities, concomitant treatments. A total of 3057 patients met the inclusion criteria. Median age: 73 (64-81) years; 55% were men; 62% smokers/ex-smokers; 56% obese/overweight. Overall, 95% of patients had chronic respiratory diseases and four comorbidities as a median. Prevalence of COVID-19: 4.8%. This was in accordance with official data during the first wave of the pandemic. The most common symptoms were respiratory: shortness of breath, cough, and pneumonia. Additionally, 53% percent of patients had mild/moderate symptoms, 28% required hospital admission, and 19% died with COVID-19. The percentage of patients hospitalized and deaths were 2.6 and 5.8 times higher, respectively, in the COVID-19 group (p
SN 2079-6382
YR 2021
FD 2021-08-25
LK https://hdl.handle.net/10668/24734
UL https://hdl.handle.net/10668/24734
LA en
DS RISalud
RD Apr 11, 2025